Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Obtains ANDA Approval For Generic GoLytely
The polyethylene glycol (PEG) and electrolytes solution is used to clean the colon (large bowel or lower intestine) before certain tests or surgery of the colon. The PEG-electrolyte
The polyethylene glycol (PEG) and electrolytes solution is used to clean the colon (large bowel or lower intestine) before certain tests or surgery of the colon. The PEG-electrolyte
The company said that with PicoPlex technology, the same amount of genomic data for analysis can be obtained from a single human cell or from 10,000 cells, with
The first, covering human microRNA miR-21, was derived from the ‘Tuschl III’ patent series that is assigned to the Max Planck Society, Berlin, Germany and is used in
Tykerb is now indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer, that overexpresses the HER2 receptor for whom
In the Notice Letter, Teva alleges that three patents associated with Tenofovir Disoproxil – US Patent numbers 5922695, 5977089 and 6043230, and one patent associated with Tenofovir Disoproxil
The company’s data supports the notion that the negative feedback of exogenous testosterone administered by any route suppresses the hypothalamic–pituitary axis and hence spermatogenesis. The discussion with the
Y C Lee, chief executive officer of Pacgen, said: “Pacgen is very pleased to collaborate with New Summit Bio to develop PAC-113 for the Chinese market. China represents
In addition to the upfront payments, Patrys will also receive a number of milestone payments in the first 30 months of the agreement, and beyond, if development goals
The additional funding follows recognition of the ReCell regenerative technology as a crucial technology in the Department of Defense’s AFIRM program. Avita was awarded the additional grant following
Stirling’s botanical extract, ImmunoXel has already been shown to decrease the duration of the flu in clinical trial participants by 2 – 3 days. The company claims that